CytomX Therapeutics, Inc.

CTMX · NASDAQ
Analyze with AI
$4.11−$0.14 (−3.29%)
At close:Dec 17, 2025, 9:00 PM UTC
$4.04−$0.07 (−1.7%)
After hours:Dec 17, 2025, 11:23 PM UTC
P/E TTM24.2
P/B TTM6.32
P/S TTM6.13
Dividend Yield0%
EPS$0.30
Beta2.369
Valuation
PEG Ratio-0.88
FCF Yield-10.39%
EV / EBITDA27.37
More On Valuation »
Quality
ROIC18.76%
Gross Margin94.75%
Cash Conv. Ratio-2.58
More On Quality »
Growth
Revenue 3Y CAGR37.47%
FCF Growth-52.16%
More On Growth »
Safety
Net Debt / EBITDA-1.17
Interest Coverage0.00
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-674.28
More On Efficiency »

CytomX Therapeutics, Inc. (CTMX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is CytomX Therapeutics, Inc. (CTMX) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, CytomX Therapeutics, Inc. (CTMX) stock is trading at $4.11. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CTMX stock quotes for informed trading decisions.

What is CytomX Therapeutics, Inc.'s market capitalization?

CytomX Therapeutics, Inc. (CTMX) has a market capitalization of approximately $696.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare CytomX Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CTMX stock price changes.

What is the 52-week range for CytomX Therapeutics, Inc. stock?

CytomX Therapeutics, Inc. (CTMX) stock has traded in a 52-week range of $0.40 — $4.62. The 52-week range shows the highest and lowest prices at which CTMX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current CytomX Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does CytomX Therapeutics, Inc. stock have?

CytomX Therapeutics, Inc. (CTMX) stock recently traded approximately 3.8M shares. Trading volume indicates market liquidity and investor interest in CTMX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting CytomX Therapeutics, Inc. stock.

Does CytomX Therapeutics, Inc. pay dividends to shareholders?

Yes, CytomX Therapeutics, Inc. (CTMX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate CytomX Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is CytomX Therapeutics, Inc.'s intraday price range?

Today, CytomX Therapeutics, Inc. (CTMX) stock has traded in a range of $3.98 — $4.37. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CTMX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get CytomX Therapeutics, Inc. stock data?

AlphaPilot sources real-time CTMX stock quotes, fundamental financial data, and historical price charts for CytomX Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The CytomX Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CTMX stock performance.